78 related articles for article (PubMed ID: 12778072)
1. Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray.
Hedberg Y; Ljungberg B; Roos G; Landberg G
Br J Cancer; 2003 May; 88(9):1417-23. PubMed ID: 12778072
[TBL] [Abstract][Full Text] [Related]
2. Loss of nuclear p27(kip1) and α-dystroglycan is a frequent event and is a strong predictor of poor outcome in renal cell carcinoma.
Sgambato A; Camerini A; Genovese G; De Luca F; Viacava P; Migaldi M; Boninsegna A; Cecchi M; Sepich CA; Rossi G; Arena V; Cittadini A; Amoroso D
Cancer Sci; 2010 Sep; 101(9):2080-6. PubMed ID: 20626751
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evaluation of oral epithelial dysplasia using cyclin-D1, p27 and p63 expression as predictors of malignant transformation.
Ramasubramanian A; Ramani P; Sherlin HJ; Premkumar P; Natesan A; Thiruvengadam C
J Nat Sci Biol Med; 2013 Jul; 4(2):349-58. PubMed ID: 24082731
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of NFIA as a novel prognostic marker in renal cell carcinoma.
de Alwis R; Schoch S; Islam M; Möller C; Ljungberg B; Axelson H
J Pathol Clin Res; 2023 Jul; 9(4):261-272. PubMed ID: 36947439
[TBL] [Abstract][Full Text] [Related]
5. Downstream Targets of VHL/HIF-α Signaling in Renal Clear Cell Carcinoma Progression: Mechanisms and Therapeutic Relevance.
Mazumder S; Higgins PJ; Samarakoon R
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831657
[TBL] [Abstract][Full Text] [Related]
6. G6PD upregulates Cyclin E1 and MMP9 to promote clear cell renal cell carcinoma progression.
Zhang Q; Ni Y; Wang S; Agbana YL; Han Q; Liu W; Bai H; Yi Z; Yi X; Zhu Y; Sai B; Yang L; Shi Q; Kuang Y; Yang Z; Zhu Y
Int J Med Sci; 2022; 19(1):47-64. PubMed ID: 34975298
[No Abstract] [Full Text] [Related]
7. Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma.
Petitprez F; Ayadi M; de Reyniès A; Fridman WH; Sautès-Fridman C; Job S
Front Oncol; 2021; 11():643065. PubMed ID: 33996558
[No Abstract] [Full Text] [Related]
8. Artesunate Inhibits Growth of Sunitinib-Resistant Renal Cell Carcinoma Cells through Cell Cycle Arrest and Induction of Ferroptosis.
Markowitsch SD; Schupp P; Lauckner J; Vakhrusheva O; Slade KS; Mager R; Efferth T; Haferkamp A; Juengel E
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33121039
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-322 Regulates Self-renewal of Mouse Spermatogonial Stem Cells through
Wang Y; Li X; Gong X; Zhao Y; Wu J
Int J Biol Sci; 2019; 15(4):857-869. PubMed ID: 30906216
[TBL] [Abstract][Full Text] [Related]
10. Expression of Aldehyde Dehydrogenase 1A1 (ALDH1A1) as a Prognostic Biomarker in Colorectal Cancer Using Immunohistochemistry.
Yang W; Wang Y; Wang W; Chen Z; Bai G
Med Sci Monit; 2018 May; 24():2864-2872. PubMed ID: 29748529
[TBL] [Abstract][Full Text] [Related]
11. G6PD promotes renal cell carcinoma proliferation through positive feedback regulation of p-STAT3.
Zhang Q; Yang Z; Han Q; Bai H; Wang Y; Yi X; Yi Z; Yang L; Jiang L; Song X; Kuang Y; Zhu Y
Oncotarget; 2017 Dec; 8(65):109043-109060. PubMed ID: 29312589
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol inhibits canonical Wnt signaling in human MG-63 osteosarcoma cells.
Zou Y; Yang J; Jiang D
Mol Med Rep; 2015 Nov; 12(5):7221-6. PubMed ID: 26398440
[TBL] [Abstract][Full Text] [Related]
13. DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells.
Chu Q; Han N; Yuan X; Nie X; Wu H; Chen Y; Guo M; Yu S; Wu K
J Hematol Oncol; 2014 Oct; 7():73. PubMed ID: 25322986
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ovarian cancer cell proliferation by Pien Tze Huang via the AKT-mTOR pathway.
He F; Wu HN; Cai MY; Li CP; Zhang X; Wan Q; Tang SB; Cheng JD
Oncol Lett; 2014 Jun; 7(6):2047-2052. PubMed ID: 24932287
[TBL] [Abstract][Full Text] [Related]
15. Validation of housekeeping gene and impact on normalized gene expression in clear cell renal cell carcinoma: critical reassessment of YBX3/ZONAB/CSDA expression.
Dupasquier S; Delmarcelle AS; Marbaix E; Cosyns JP; Courtoy PJ; Pierreux CE
BMC Mol Biol; 2014 May; 15():9. PubMed ID: 24885929
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of cyclin D1 in renal cell carcinoma.
Lima MS; Pereira RA; Costa RS; Tucci S; Dantas M; Muglia VF; Ravinal RC; Barros-Silva GE
Int Urol Nephrol; 2014 May; 46(5):905-13. PubMed ID: 24242739
[TBL] [Abstract][Full Text] [Related]
17. PI3K regulation of the SKP-2/p27 axis through mTORC2.
Shanmugasundaram K; Block K; Nayak BK; Livi CB; Venkatachalam MA; Sudarshan S
Oncogene; 2013 Apr; 32(16):2027-36. PubMed ID: 22733130
[TBL] [Abstract][Full Text] [Related]
18. Emerging critical role of molecular testing in diagnostic genitourinary pathology.
Netto GJ; Cheng L
Arch Pathol Lab Med; 2012 Apr; 136(4):372-90. PubMed ID: 22458900
[TBL] [Abstract][Full Text] [Related]
19. Targeting mTOR in cancer: renal cell is just a beginning.
Azim H; Azim HA; Escudier B
Target Oncol; 2010 Dec; 5(4):269-80. PubMed ID: 20563661
[TBL] [Abstract][Full Text] [Related]
20. The sonic hedgehog signaling pathway is reactivated in human renal cell carcinoma and plays orchestral role in tumor growth.
Dormoy V; Danilin S; Lindner V; Thomas L; Rothhut S; Coquard C; Helwig JJ; Jacqmin D; Lang H; Massfelder T
Mol Cancer; 2009 Dec; 8():123. PubMed ID: 20015350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
